Ditchcarbon
  • Contact
  1. Organizations
  2. Q-Med AB
Public Profile
Research Pending

This profile hasn't yet passed our validation checks

Submit your email to push it up the queue

We'll prioritize this organization's research and notify you when detailed sustainability data becomes available.

Pharmaceutical Preparation Manufacturing
SE
updated a month ago

Q-Med AB

Company website

Q-Med AB, a pioneering company in the medical technology sector, is headquartered in Sweden (SE) and operates extensively across Europe and North America. Founded in 1988, Q-Med has established itself as a leader in the development of innovative hyaluronic acid-based products, particularly in the fields of aesthetics and regenerative medicine. The company’s flagship offerings include the renowned Restylane® range, which revolutionised facial aesthetics, and other advanced medical devices that enhance patient care. Q-Med's commitment to quality and scientific research has positioned it as a trusted name in the industry, with numerous accolades highlighting its contributions to healthcare. With a focus on improving patient outcomes, Q-Med continues to drive advancements in medical technology, solidifying its reputation as a key player in the global market.

DitchCarbon Score

How does Q-Med AB's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

35

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Q-Med AB's score of 35 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.

60%

Let us know if this data was useful to you

Q-Med AB's reported carbon emissions

Inherited from Galderma Group AG

Q-Med AB, headquartered in Sweden (SE), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Galderma Group AG, which may influence its climate commitments and reporting practices. As of now, Q-Med AB has not established any documented reduction targets or climate pledges. The lack of specific emissions data and reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the context of its parent company, Galderma Group AG, it is possible that Q-Med AB's climate commitments could align with broader initiatives undertaken by the group, although specific details are not available at this time. In summary, Q-Med AB's current climate commitments and emissions data remain unspecified, reflecting a potential area for future development in sustainability practices.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20222023
Scope 1
-
0,000,000
Scope 2
5,600,000
0,000,000
Scope 3
-
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Q-Med AB's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Q-Med AB is in SE, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Q-Med AB is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Carbon Medical Technologies, Inc.

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 24 days ago

Contura International A/S

DK
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 22 days ago

Cogentix Medical, Inc.

US
•
Health and social work services (85)
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251005.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy